Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shanti D'Souza
Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Gamaglobulin Infusion in Patients With Severe Atopic Dermatitis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Induction of Human Regulatory Innate Lymphoid Cells From Group 2 Innate Lymphoid Cells by Retinoic Acid
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Reduced Numbers of Circulating Group 2 Innate Lymphoid Cells in Patients With Common Variable Immunodeficiency
European Journal of Immunology
Allergy
Immunology
Real‐world Use of Dupilumab for 53 Patients With Atopic Dermatitis in Japan
Journal of Cutaneous Immunology and Allergy
Pulmonary Group 2 Innate Lymphoid Cells: Surprises and Challenges
Mucosal Immunology
Allergy
Immunology
PD-1 Regulates KLRG1 + Group 2 Innate Lymphoid Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Effectiveness of Dupilumab Treatment in 95 Patients With Atopic Dermatitis: Daily Practice Data
British Journal of Dermatology
Dermatology
Medicine
Dupilumab for the Treatment of Atopic Dermatitis
Prescriber
Pharmacology